Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 626 of 1,261
  1. US 9682075

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Collegium Pharmaceutical, Inc. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  2. US 9682052

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  3. US 9683985

    Methods for assessing and identifying or evolving conditionally active therapeutic proteins

    HALOZYME, INC. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  4. US 9675591

    Methods for treating seizure disorders and pain

    The Regents of the University of California · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  5. US 9676857

    Soluble engineered monomeric Fc

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  6. US 9677052

    Modified lipopolysaccharide glycoform and method of use

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  7. US 9676809

    Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections

    Ligand Pharmaceuticals Incorporated · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  8. US 9678060

    Lunasin-induced regulation of disease-related gene expression

    The Regents of the University of California · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  9. US 9676779

    Small molecule CFTR correctors

    DISCOVERYBIOMED, INC. · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  10. US 9676771

    Compounds for inhibiting drug-resistant strains of HIV-1 integrase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  11. US 9676759

    Isoindolinone inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  12. US 9675697

    BET bromodomain inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  13. US 9675692

    Stabilized formulations containing anti-DLL4 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  14. US 9675684

    Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome

    The United States of America as represented by the Secretary of the Army · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  15. US 9676746

    Crystalline forms of C21H22Cl2N4O2

    Vertex Pharmaceuticals Incorporated · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  16. US 9675649

    Disialyllacto-N-tetraose (DSLNT) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease

    The Regents of the University of California · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  17. US 9675653

    Composition containing an essential oil product and method for using such to maintain normal levels of testosterone

    YOUNG LIVING ESSENTIAL OILS, LC · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  18. US 9675676

    Factor IX polypeptides and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  19. US 9675651

    Method for increasing performance of offspring

    JBS UNITED, INC. · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  20. US 9675637

    Use of nitrite salts for the treatment of cardiovascular conditions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  21. US 9675633

    miRNA for treating cancer and for use with adoptive immunotherapies

    The Board of Regents of the University of Texas System · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  22. US 9675632

    Nucleoside and nucleotide derivatives

    Enanta Pharmaceuticals, Inc. · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  23. US 9675618

    Drug combinations and uses in treating a coughing condition

    Infirst Healthcare Limited · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  24. US 9675663

    TUSC2 therapies

    The Board of Regents of the University of Texas System · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.